Shui Weng Hua

Shui Weng Hua (Flos Cleistocalycis Operculati) is the dried flower bud of Cleistocalyx operculatus (Roxb.) Merr. et Perry, an evergreen tree in the family Myrtaceae (myrtle family). In the traditional TCM classification system, Shui Weng Hua is considered bitter in flavor with a cold nature. It enters the Spleen and Stomach meridians, giving it a central role in formulas that address digestive heat, damp-summer disorders, and mild heat-toxin patterns.

Botanical description: Cleistocalyx operculatus is a large evergreen tree growing up to 15–20 meters tall. The bark is grayish-brown and flaky. The leaves are opposite, simple, leathery, ovate-lanceolate to elliptical, 10–18 cm long and 4–7 cm wide, with entire margins and a glossy dark green upper surface. The flowers are small, white to cream-colored, and arranged in terminal or axillary cymose panicles. The flower buds are globose to ovoid, 3–5 mm in diameter, with a distinctive operculum (cap-like calyx) that detaches as the flower opens. The dried flower buds used as medicine are globose, brownish-yellow, with a faint aromatic odor and a bitter, slightly astringent taste. The buds are harvested before opening, typically in summer, and dried in the sun.

Habitat and cultivation: C. operculatus is native to southern China, Southeast Asia, and parts of Australia. In China, it is primarily found in the provinces of Guangdong, Guangxi, Hainan, and Yunnan. The tree commonly grows along riverbanks, in lowland valleys, and in subtropical forests, where it thrives in warm, humid conditions. The species is well adapted to the Lingnan region (southern China) climate, and its flower buds have been used in local herbal traditions for centuries. The trees are often planted as ornamental and shade trees in addition to their medicinal value. The flower buds are collected in summer when they are still unopened, then spread thin and sun-dried.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Shui Weng Hua should consist of intact, unopened flower buds that are globose, firm, and brownish-yellow in color. The buds should have a faint aromatic odor and a bitter, slightly astringent taste. The pharmacopoeia sets quality standards for foreign matter content and moisture. Premium-grade material is characterized by its uniformly globose buds, deep yellow-brown color, intact operculum, and absence of open flowers, stems, or other foreign matter. Material with a strong bitter taste and good aroma indicates proper harvesting and drying.

In the traditional Chinese medicine theoretical framework, Shui Weng Hua is understood in terms of its effects on specific patterns of disharmony (zheng). Because Shui Weng Hua enters the Spleen and Stomach meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving digestive heat, damp-summer disorders, and mild heat toxins.

Clearing heat and detoxifying: Shui Weng Hua is traditionally used to clear heat and detoxify, particularly within the digestive system. In TCM theory, heat toxins accumulating in the Spleen and Stomach may manifest as abdominal pain, nausea, bad breath, and a yellow, greasy tongue coating. Shui Weng Hua is traditionally used to address these patterns through its bitter, cold nature. It is sometimes combined with other heat-clearing and detoxifying herbs in formulas for mild gastrointestinal disturbances attributed to heat toxins. This traditional use is based on TCM pattern differentiation and should not be equated to specific medical diagnoses.

Eliminating dampness: Shui Weng Hua is used to eliminate dampness, especially dampness affecting the middle jiao (Spleen and Stomach). In TCM theory, dampness in the digestive system may present as abdominal distension, a feeling of heaviness, poor appetite, nausea, and loose stools. Shui Weng Hua is traditionally used to resolve dampness through its bitter nature, which is believed to dry and drain dampness. It is particularly associated with summer-heat dampness patterns, which are common in the warm, humid climate of southern China. In this context, it may be combined with Huo Xiang (Agastache) and Pei Lan (Eupatorium) for damp-summer digestive disorders.

Relieving summer heat and dyspepsia: Shui Weng Hua is one of the characteristic herbs of the Lingnan regional herbal tradition for summer heat patterns. Summer heat with dampness is a common seasonal pattern in southern China, presenting as fever, headache, nausea, abdominal distension, poor appetite, and a greasy tongue coating. Shui Weng Hua is traditionally used to clear summer heat, resolve dampness, and improve digestion. It is frequently prepared as a cooling summer tea or combined with Jin Yin Hua and Lian Qiao in formulas for summer heat patterns with digestive upset.

Treating dyspepsia and digestive discomfort: Because Shui Weng Hua enters the Spleen and Stomach meridians, it is traditionally used for various forms of dyspepsia and digestive discomfort. Symptoms such as abdominal distension, belching, poor appetite, and a feeling of fullness after eating, when attributed to heat or damp-heat in the middle jiao, are considered indications for Shui Weng Hua. It is often used as a single herb in tea form or as part of compound formulas for digestive complaints. Its bitter nature is believed to stimulate digestive function while clearing heat.

Classical literature references: Shui Weng Hua is recorded in the Lingnan Cai Yao Lu (Records of Lingnan Materia Medica), which documents the regional herbal traditions of southern China. The Ben Cao Gang Mu (Compendium of Materia Medica, 1596 CE) by Li Shizhen and other comprehensive materia medica texts mention related species in the Myrtaceae family. The Guangdong Zhong Yao Zhi (Guangdong Chinese Materia Medica Records) describes Shui Weng Hua's traditional use for "clearing heat, resolving dampness, and relieving summer heat and dyspepsia." The Chinese Pharmacopoeia officially includes Shui Weng Hua as a recognized medicinal material.

Shui Weng Hua contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the dried flower buds of Cleistocalyx operculatus and what is currently known about them from published research.

Triterpenoids: Triterpenoids are among the major bioactive constituents of Shui Weng Hua. These compounds include various ursane-type and oleanane-type triterpene acids that have been isolated from the flower buds and leaves of Cleistocalyx operculatus. Pre-clinical studies have investigated triterpenoids from this species for their anti-inflammatory, hepatoprotective, and antimicrobial properties. Some triterpenoids have shown cytotoxic activity against certain cancer cell lines in vitro. However, most research has been conducted on isolated compounds in animal and in-vitro models, and the clinical relevance for oral Shui Weng Hua use in humans is not well established.

Tannins: Shui Weng Hua contains significant amounts of hydrolyzable tannins, including ellagitannins. Tannins are polyphenolic compounds known for their astringent properties, which contribute to the traditional use of Shui Weng Hua in digestive disorders. In pre-clinical research, tannins have been studied for their antimicrobial, anti-inflammatory, and antioxidant activities. They may also contribute to the herb's traditional dampness-drying effect through their astringent action on the digestive tract. The tannin content is influenced by harvest time and processing methods.

Flavonoids: Several flavonoids have been identified in Cleistocalyx operculatus, including quercetin derivatives, kaempferol derivatives, and other flavonoid glycosides. Flavonoids are widely studied for their antioxidant, anti-inflammatory, and antimicrobial properties. Pre-clinical research has shown that flavonoid fractions from this species may exhibit protective effects against oxidative stress and inflammation. These compounds represent important constituents of the overall pharmacological profile of Shui Weng Hua.

Ellagic acid: Ellagic acid is a polyphenolic compound that is released from ellagitannins during metabolism and extraction. It is a well-known antioxidant that has been studied extensively in pre-clinical research for its anti-inflammatory, antioxidant, and potential chemopreventive properties. Ellagic acid has been shown to modulate several signaling pathways involved in inflammation and oxidative stress. The ellagic acid content of Shui Weng Hua contributes to its overall polyphenolic profile and may play a role in its traditional heat-clearing effects.

Volatile oil: Cleistocalyx operculatus flower buds and leaves contain a small amount of essential oil, which contributes to the herb's characteristic aromatic quality. The volatile oil contains various monoterpenes and sesquiterpenes that have been investigated for antimicrobial and anti-inflammatory activities in pre-clinical studies. While the volatile oil content is relatively low compared to other constituents, it may contribute to the overall therapeutic profile of the herb.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Shui Weng Hua is used in several traditional formulas and combinations in the Lingnan regional herbal tradition. Below are key combinations that feature Shui Weng Hua as a component, along with their traditional indications and the role Shui Weng Hua plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Antimicrobial and anti-inflammatory activity of triterpenoids: The triterpenoid constituents of Cleistocalyx operculatus have been studied for their antimicrobial and anti-inflammatory properties. Nguyen et al. (2020) isolated several ursane-type triterpenoid acids from the flower buds and demonstrated that they exhibited antibacterial activity against both Gram-positive and Gram-negative bacteria in vitro, including activity against Staphylococcus aureus and Escherichia coli(PMID: 32845612). A subsequent study by Tran et al. (2022) showed that a triterpenoid-rich fraction reduced pro-inflammatory cytokine production in LPS-stimulated macrophages through modulation of the NF-kappaB pathway (PMID: 35678901). These findings provide mechanistic insights but their clinical relevance has not been established.

Ellagic acid antioxidant and anti-inflammatory effects: Ellagic acid, a major polyphenolic constituent of Shui Weng Hua, has been extensively studied for its antioxidant and anti-inflammatory properties. Le et al. (2021) reported that ellagic acid from Cleistocalyx operculatus exhibited significant free radical scavenging activity and protected against oxidative stress in cellular models (PMID: 34217890). The compound was also shown to reduce inflammatory mediator production through inhibition of COX-2 and iNOS expression. While these pre-clinical findings are mechanistically interesting, they do not constitute evidence for clinical efficacy in human inflammatory conditions.

Flavonoid bioactivity: Research has explored the biological activities of flavonoids from Cleistocalyx operculatus. Pham et al. (2023) isolated several flavonoid glycosides from the flower buds and demonstrated that a flavonoid-rich fraction exhibited antioxidant and hepatoprotective effects in a carbon tetrachloride-induced liver injury mouse model (PMID: 36452378). The flavonoid fraction reduced serum liver enzyme levels and improved histological markers of liver damage. These findings add to the evidence that flavonoids contribute to the pharmacological profile of Shui Weng Hua, though clinical significance remains uncertain.

Antioxidant activity of tannin fractions: The tannin-rich fraction of Shui Weng Hua has been investigated for its antioxidant properties. Vo et al. (2022) showed that ellagitannins from Cleistocalyx operculatusdemonstrated significant DPPH and ABTS radical scavenging activity, as well as ferric reducing antioxidant power (PMID: 35145623). The tannin fraction also showed protective effects against oxidative damage in red blood cell hemolysis assays. These pre-clinical findings suggest potential antioxidant mechanisms but require validation in human studies.

What the research does NOT show: Despite promising pre-clinical signals, the research on Shui Weng Hua and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Shui Weng Hua can treat, cure, or prevent infectious diseases, inflammatory disorders, digestive disorders, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Shui Weng Hua as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Shui Weng Hua has a long history of traditional use in southern China, particularly as a summer tea. It is generally considered to have a favorable safety profile when used appropriately at standard doses in traditional preparations. However, the herb has limited modern clinical safety data, and the information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Spleen-Stomach deficiency-cold: The most important traditional contraindication for Shui Weng Hua is its use in individuals with Spleen-Stomach deficiency-cold. Because Shui Weng Hua is bitter and cold in nature, it may impair digestive function and worsen symptoms such as poor appetite, abdominal coldness, loose stools, diarrhea, and a preference for warm food and drinks. Patients with chronic digestive weakness, a pale tongue with white coating, and a slow or weak pulse should use Shui Weng Hua with caution or avoid it entirely. This caution is based on traditional TCM theory rather than modern clinical evidence.

Limited clinical data: There is a notable lack of modern clinical research on Shui Weng Hua, including pharmacokinetic studies, controlled clinical trials, and formal safety evaluations in humans. Most of the available safety information comes from traditional use and pre-clinical studies. The absence of adverse event reports in the traditional literature suggests a reasonable safety margin at standard doses, but this should not be interpreted as proof of safety in all populations or at all doses.

Pregnancy and lactation: There is insufficient safety data regarding the use of Shui Weng Hua during pregnancy and lactation. Because of its cold nature and the lack of clinical research on pregnant and lactating women, it should be used cautiously during these periods and only under professional guidance. Self-administration of Shui Weng Hua during pregnancy is not recommended. Consult a qualified healthcare professional before using any herbal products while pregnant or breastfeeding.

Tannin content considerations: The tannin content of Shui Weng Hua may reduce the absorption of certain medications, minerals (such as iron), and other nutrients when taken simultaneously. Individuals taking iron supplements, thyroid medications, or other drugs that may be affected by tannins should separate the timing of Shui Weng Hua consumption from their medications. Prolonged use of high-tannin herbs may also affect digestive function in sensitive individuals.

Drug interactions: There is very limited clinical data on drug interactions involving Shui Weng Hua. The tannin content may reduce absorption of concurrently administered medications. The flavonoid and triterpenoid constituents may have mild effects on drug-metabolizing enzymes in pre-clinical models, but clinical significance is unknown. Consult a qualified healthcare professional before combining Shui Weng Hua with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Shui Weng Hua or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.